4 Stocks Showing Strong Relative Price Strength Right Now
GLDD, SFM, EVER and EHC are four stocks with explosive relative price strength.
Best Growth Stocks to Buy for May 19th
GLDD, EHC and UIS made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 19, 2025.
Encompass Health Corporation (EHC) Hits Fresh High: Is There Still Room to Run?
Encompass Health (EHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Encompass Health to Expand Florida Presence With New 50-bed Facility
EHC already boasts a massive footprint of 167 hospitals in 38 states and Puerto Rico.
Encompass Health (EHC) Upgraded to Strong Buy: Here's Why
Encompass Health (EHC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Here's Why Encompass Health (EHC) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Encompass Health (EHC) is a Top-Ranked Value Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Encompass Health Beats Q1 Earnings Estimates, Ups '25 EPS View
EHC's Q1 results benefit on the back of discharge growth and expansion endeavors, partly offset by high operating costs. It currently expects 2025 adjusted EPS from continuing operations within $4.85-$5.10.
Encompass Health Corporation (EHC) Hits Fresh High: Is There Still Room to Run?
Encompass Health (EHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here's What Key Metrics Tell Us About Encompass Health (EHC) Q1 Earnings
Although the revenue and EPS for Encompass Health (EHC) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Encompass Health (EHC) Surpasses Q1 Earnings and Revenue Estimates
Encompass Health (EHC) came out with quarterly earnings of $1.37 per share, beating the Zacks Consensus Estimate of $1.19 per share. This compares to earnings of $1.12 per share a year ago.
Are Medical Stocks Lagging Encompass Health (EHC) This Year?
Here is how Encompass Health (EHC) and Heron Therapeutics (HRTX) have performed compared to their sector so far this year.
